Filed under: Comfort Zone InvestingTed Allrich is the founder of The Online Investor and author of the just released book: Comfort Zone Investing: Build Wealth And Sleep Well At Night. In this weekly column, he'll offer advice to investors who are just getting started.It was the best of times; it was the worst of times. Too bad that's already been used, because it's the perfect opening for two stocks in the biotech sector. One of them flopped like a boxer hit with a perfect right hook while the other soared like a Cape Canaveral rocket. Here's what happened.The first stock, Hollis-Eden Pharmaceuticals, (NASDAQ: HEPH) developed a drug that will fight acute radiation syndrome (ARS), or at least it did in mice and macaques. The efficacy can't be treated ...